Kolexia
Chalayer Émilie Médecine interne
Chalayer Émilie
Médecine interne
Institut de Cancérologie de la Loire Lucien Neuwirth
Saint-Priest-en-Jarez, France
77 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Myélome multiple Thromboembolisme veineux Thrombose Thromboembolie Thrombopénie Lymphomes Leucémies Hémorragie Lupus érythémateux disséminé

Collaborateurs

Voir plus
Tardy Bernard
Tardy Bernard
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Guyotat Denis
Guyotat Denis
Hôpital les Chanaux, Mâcon, France
Cathebras Pascal
Cathebras Pascal
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Tavernier-Tardy Emmanuelle
Tavernier-Tardy Emmanuelle
Institut de Cancérologie de la Loire Lucien Neuwirth, Saint-Priest-en-Jarez, France

Industries

Voir plus
Sanofi
12 collaboration(s)
Dernière en 2023
Janssen
9 collaboration(s)
Dernière en 2023
Abbvie
3 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
3 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Talquetamab - multiple myeloma after at least three prior lines of therapy.
Bulletin du cancer   07 mars 2024
FORMAT: Administration of Fibrinogen Concentrate for Refractory Bleeding in Hematological Patients With Intensive Chemotherapy-induced Thrombocytopenia - Analysis Using Viscoelastic Haemostatic Assay (FORMAT)
Essai Clinique (CHU Saint-Étienne)   01 mars 2024
VESICOM: Evaluation of Predictive Biomarkers in de Novo Multiple Myeloma on the Onset of Venous Thromboembolism, Its Impact on Clinical Outcome and Thromboprophylaxis (VESICOM)
Essai Clinique (CHU Saint-Étienne)   06 février 2024
PHARM-LMC: Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia: PHARM-LMC Study
Essai Clinique (CHU Saint-Étienne)   09 janvier 2024
Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group.
Thrombosis research   02 décembre 2023
Retrospective multicenter comparative study of the efficacy and safety between R-DHAC and R-DHAOx in diffuse large B-cell lymphoma or transformed follicular or marginal zone B lymphoma into aggressive lymphoma, as a second-line treatment.
Leukemia & lymphoma   15 novembre 2023
Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)
65th ASH Annual Meeting Abstracts   02 novembre 2023
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
Essai Clinique (CHU Brest)   27 octobre 2023
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC.
Bone marrow transplantation   31 août 2023
The place of IPA in the follow-up of elderly patients with acute myeloid leukemia.
Soins; la revue de reference infirmiere   21 juin 2023